From 1 November 2020 Prezista® (darunavir) 150 mg tablets, used in combination with other antiretroviral agents for HIV treatment, will be discontinued for supply in Australia and removed from the Pharmaceutical Benefits Scheme.
Nominations for the NAPWHA Board of Directors is now open until Friday 30 October 2020. This is a fantastic opportunity for inspirational leaders who have a genuine passion for advancing the rights of people living with HIV.
Living Positive Victoria (LPV) CEO, Richard Keane highlights PLHIV community concerns for re-engage with healthcare during a year of COVID-19 restrictions. LPV are part of the Collaboration of Care who launched #DontWaitMate — a new health promotion campaign encouraging Australians to not to delay vital ongoing visits to healthcare providers that are needed to manage chronic conditions or to address new symptoms.
Anth McCarthy of Living Positive Victoria speaks to Dr John Rule (NAPWHA Senior Research Manager) about the invaluable role of peer navigation and support, fittingly during the COVID-19 lockdown in Victoria.
Kirsty Machon, Executive Director of Positive Women Victoria shares stories about life and times, resilience and community during COVID-19 with Dr John Rule (NAPWHA Senior Research Manager) during the Melbourne lockdown.
Richard Keane, CEO of Living Positive Victoria shares stories about life and times, resilience and community during COVID-19 with Dr John Rule (NAPWHA Senior Research Manager) during the Melbourne lockdown.